« previous next »
Pages: [1]

Author Topic: Two new MS drugs being developed: umbralisib (TGR-1202), ublituximab (TG-1101)  (Read 233 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9841
  • MS diagnosed 1980
  • Location: Pacific Northwest
(CMSC2018) MS patients treated w/ublituximab show benefits in Phase 2 study
« on: June 09, 2018, 04:26:59 pm »
From Multiple Sclerosis News Today (June 5, 2018)--"CMSC2018:  MS Patients Treated with Ublituximab Show Benefits in Phase 2 Study" (results presented at the Consortium of Multiple Sclerosis Centers 2018 conference, May 30 - June 2):


https://multiplesclerosisnewstoday.com/2018/06/05/cmsc2018-phase-2-study-supports-ublituximab-efficacy-in-relapsing-multiple-sclerosis/?utm_source=Multiple+Sclerosis&utm_campaign=6819f167ac-RSS_US_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_b5fb7a3dae-6819f167ac-71286581
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
1 Replies
311 Views 		Last post June 03, 2020, 02:57:56 pm
by agate
0 Replies
183 Views 		Last post August 09, 2017, 06:07:31 am
by agate
3 Replies
45 Views 		Last post February 28, 2023, 04:31:39 pm
by agate
0 Replies
18 Views 		Last post October 18, 2023, 03:45:11 pm
by agate
0 Replies
5 Views 		Last post February 26, 2024, 08:54:48 pm
by agate